Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value
$71.97−1.66 (-2.25%)
Close on Nov 13, 2026Market cap $229.14MP/E 21.5Yield –
Utah Medical Products cash
Cash and short-term investments held at the end of each period.
Utah Medical Products's cash was $85.20M at Sep 30, 2026. For fiscal 2025 it was $85.76M, up 3.4% from the year before. Over ten years it grew 13.9% a year on average. The highest annual figure on record is $92.87M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.76M | +3.4% |
| FY2024 | Dec 31, 2024 | $82.98M | -10.7% |
| FY2023 | Dec 31, 2023 | $92.87M | +23.7% |
| FY2022 | Dec 31, 2022 | $75.05M | +23.1% |
| FY2021 | Dec 31, 2021 | $60.97M | +18.2% |
| FY2020 | Dec 31, 2020 | $51.59M | +20.6% |
| FY2019 | Dec 31, 2019 | $42.79M | -16.3% |
| FY2018 | Dec 31, 2018 | $51.11M | +28.2% |
| FY2017 | Dec 31, 2017 | $39.88M | +51.6% |
| FY2016 | Dec 31, 2016 | $26.30M | +13.0% |
| FY2015 | Dec 31, 2015 | $23.28M | +20.8% |
| FY2014 | Dec 31, 2014 | $19.27M | +33.9% |
| FY2013 | Dec 31, 2013 | $14.40M | +62.3% |
| FY2012 | Dec 31, 2012 | $8.87M | +35.8% |
| FY2011 | Dec 31, 2011 | $6.53M | +71.1% |
| FY2010 | Dec 31, 2010 | $3.82M | +831.2% |
| FY2009 | Dec 31, 2009 | $410.00K | +322.7% |
| FY2008 | Dec 31, 2008 | $97.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $85.20M | +1.1% |
| Q2 FY2026 | Jun 30, 2026 | $87.53M | +6.5% |
| Q1 FY2026 | Mar 31, 2026 | $87.41M | +4.9% |
| Q4 FY2025 | Dec 31, 2025 | $85.76M | +3.4% |
| Q3 FY2025 | Sep 30, 2025 | $84.27M | -9.3% |
| Q2 FY2025 | Jun 30, 2025 | $82.18M | -6.8% |
| Q1 FY2025 | Mar 31, 2025 | $83.33M | -1.5% |
| Q4 FY2024 | Dec 31, 2024 | $82.98M | +2.6% |
| Q4 FY2023 | Dec 31, 2023 | $92.87M | +23.7% |
| Q3 FY2023 | Sep 30, 2023 | $88.21M | +26.9% |
| Q2 FY2023 | Jun 30, 2023 | $84.62M | +27.8% |
| Q1 FY2023 | Mar 31, 2023 | $80.91M | +22.8% |
| Q4 FY2022 | Dec 31, 2022 | $75.05M | +23.1% |
| Q3 FY2022 | Sep 30, 2022 | $69.51M | +8.1% |
| Q2 FY2022 | Jun 30, 2022 | $66.22M | +11.3% |
| Q1 FY2022 | Mar 31, 2022 | $65.87M | +17.6% |
| Q4 FY2021 | Dec 31, 2021 | $60.97M | +18.2% |
| Q3 FY2021 | Sep 30, 2021 | $64.32M | +38.9% |
| Q2 FY2021 | Jun 30, 2021 | $59.51M | +40.5% |
| Q1 FY2021 | Mar 31, 2021 | $56.03M | +41.5% |
| Q4 FY2020 | Dec 31, 2020 | $51.59M | +20.6% |
| Q3 FY2020 | Sep 30, 2020 | $46.29M | +23.8% |
| Q2 FY2020 | Jun 30, 2020 | $42.35M | +28.8% |
| Q1 FY2020 | Mar 31, 2020 | $39.61M | +21.3% |
| Q4 FY2019 | Dec 31, 2019 | $42.79M | -16.3% |
| Q3 FY2019 | Sep 30, 2019 | $37.39M | -24.2% |
| Q2 FY2019 | Jun 30, 2019 | $32.88M | -28.3% |
| Q1 FY2019 | Mar 31, 2019 | $32.67M | -23.8% |
| Q4 FY2018 | Dec 31, 2018 | $51.11M | +28.2% |
| Q3 FY2018 | Sep 30, 2018 | $49.35M | +31.8% |
| Q2 FY2018 | Jun 30, 2018 | $45.87M | +36.0% |
| Q1 FY2018 | Mar 31, 2018 | $42.85M | +39.7% |
| Q4 FY2017 | Dec 31, 2017 | $39.88M | +51.6% |
| Q3 FY2017 | Sep 30, 2017 | $37.44M | +18.6% |
| Q2 FY2017 | Jun 30, 2017 | $33.74M | +14.8% |
| Q1 FY2017 | Mar 31, 2017 | $30.68M | +11.5% |
| Q4 FY2016 | Dec 31, 2016 | $26.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $31.56M | – |
| Q2 FY2016 | Jun 30, 2016 | $29.40M | – |
| Q1 FY2016 | Mar 31, 2016 | $27.52M | – |
See a number that looks wrong?